Soaring by more than 30,000%! Jiuan Medical's net profit in the first quarter of 2022 is expected to reach 14 billion!

In the first half of 2021, Amazon's account bans swept the cross-border e-commerce industry, causing many cross-border top sellers to fall into the trap and suffer heavy losses. Among them, the parent company of cross-border sellers Zebao, Xinghui Shares, and the parent company of Youkeshu, Tianze Information, both suffered annual losses of more than 1 billion.

However, among them, there are also "chosen ones" who are not affected by it and even go against the wind.

Anker Innovations, a cross-border bestseller, is one of them.

0 1

Revenue exceeds 10 billion!

Anker Innovations' net profit reached 982 million in 2021!

It is learned that on April 12, Anker Innovations released its 2021 annual report. During the reporting period, Anker Innovations achieved revenue of 12.574 billion yuan in 2021 , a year-on-year increase of 34.45% ; the net profit attributable to shareholders of the listed company was 982 million yuan , a year-on-year increase of 14.70% .

▲ The picture comes from Anker Innovations’ performance report

The report shows that Anker Innovations' three main categories of charging, wireless audio, and smart innovation all achieved good growth. Among them:

At the same time, in 2021, Anker Innovations entered more emerging markets relying on online sales platforms such as Amazon, and on this basis deepened cooperation with well-known e-commerce platforms such as AliExpress and eBay. Among them, the Amazon platform achieved revenue of 6.873 billion yuan , a year-on-year increase of 19.04% , accounting for 54.66% of the total revenue ; the independent station achieved revenue of 393 million yuan , a year-on-year increase of 83.57% .

▲ The picture comes from Anker Innovations’ performance report

During the reporting period, while Anker Innovations continued to consolidate mature markets such as North America, Europe, and Japan, it also continued to increase its layout in important emerging markets such as mainland China, Australia, Southeast Asia, and South America. In 2021 , the revenue growth rate in countries and regions such as Europe, mainland China, and Australia exceeded 30%.

The data clearly shows that Anker Innovations' business operations once again achieved new breakthroughs in 2021, maintaining steady growth in overseas mature markets and continuously expanding its territory with an online + offline multi-channel operation model.

In addition to Anker Innovations, the recent performance forecast of another big seller is even more jaw-dropping.

0 2

A surge of over 30,000%!

iHealth’s net profit for Q1 2022 is expected to reach 14 billion!

It is learned that on April 12, iHealth released its first quarter 2022 performance forecast . During the forecast period, the net profit attributable to shareholders of the listed company is expected to be 14 billion to 16 billion , a year-on-year increase of 36,707.43% to 41,965.63% ; the net profit after deducting non-recurring gains and losses is 14 billion to 16 billion , a year-on-year increase of 738,452.44% to 843,959.93% .

▲ The picture comes from Jiuan Medical's performance forecast

At the same time, iHealth also announced its 2021 performance report. The report shows that in 2021, the company achieved a total operating income of 2.512 billion yuan , a year-on-year increase of 25.11% ; and achieved a net profit attributable to the parent company's owners of 913 million yuan , a year-on-year increase of 276.87% .

It is learned that the surge in performance in the first quarter of 2022 was mainly driven by the substantial growth in sales of COVID-19 antigen test kits. During the reporting period, iHealth sold COVID-19 antigen test kits through its own channels and the Amazon platform, and signed major contracts and orders with customers. The growth in sales revenue of this product made an important contribution to iHealth's performance during the reporting period.

However, iHealth also mentioned in the report that due to the unpredictable development of the epidemic, the advancement of vaccination plans, changes in market demand, and changes in the market competition environment, there is still a certain degree of uncertainty as to whether future performance will be able to continue to maintain rapid growth.

Looking at the performance reports of the two major sellers, Anker Innovations, relying on its forward-looking development vision, has exerted its strength in both domestic and overseas markets, and its performance has continued to show a steady upward trend. Jiuan Medical has taken advantage of the epidemic to achieve a blowout growth in product sales. It can be seen that for the cross-border e-commerce industry, if they can seize the opportunity, cross-border sellers will have a greater chance of making big sales.

What do sellers think about this?